Latest filing published 18 Mar 2025 for AIM ImmunoTech Inc., €4,798. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nancy Bryan appears in our data through filings on AIM ImmunoTech Inc. shares, published by SEC (Form 4). We count 9 filings; the first trade dates from 21 March 2024 and the latest from 14 March 2025.
No open-market sale appears; the market trades are 1 purchase worth €14k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants.
The latest filing, published on 18 March 2025, reports a share grant of €4,798 in AIM ImmunoTech Inc. The last purchase on record was published on 22 March 2024, which is 940 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations